Drug Trial Radar · NCT07514858
A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Jul 28, 2026
Primary completion
Oct 3, 2028
Study completion Oct 3, 2028
Sponsor
- Lead sponsor
- H. Lundbeck A/SIndustry
- Sponsor type
- Industry
- First posted
- Apr 7, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial will evaluate the effects of Lu AF28996 in adults with Parkinson's disease (PD) experiencing motor fluctuations despite optimized non-invasive symptomatic treatment. These are individuals with PD who take medications to control movement symptoms, such as slowness, stiffness, and tremor, but still experience periods of time when their medication does not adequately control their motor symptoms. Some may also experience dyskinesia (other type of involuntary movements) as a side effect of their PD medications. The main goal of the trial is to learn whether adding Lu AF28996 to participants' optimized PD medications will help extending the time they spend with their movement symptoms being well-controlled and without bothersome dyskinesia.
Conditions
- Parkinson's Disease
Interventions
Lu AF28996Drug
Lu AF28996 will be administered orally per schedule specified in the arm description.
PlaceboDrug
Placebo matching to Lu AF28996 will be administered orally per schedule specified in the arm description.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Week 19 in Daily Good ON Time Based on the Participant's Hauser Diary EntriesTime frame: Baseline, Week 19
Locations
6 sites in 4 countries. Site status is shown where the registry gives one.
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida · Recruiting
QUEST Research Institute
Farmington, Michigan · Recruiting
Central Texas Neurology Consultants (CTNC)
Round Rock, Texas · Recruiting
Praglandia s.r.o.
Prague, Praha, Hlavni Mesto, Czechia · Recruiting
Curiositas Ad Sanum - Haag In Oberbayern
Haag I.Ob, Bavaria, Germany · Recruiting
European Trial group network Sp. z o.o - Neuroscience
Warsaw, Masovian Voivodeship, Poland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.